NCT01689610

Non-interventional Study With Nab-Paclitaxel (Abraxane®)

Non-Interventional Study to Investigate Efficacy and Safety of Nab-Paclitaxel in Patients With Metastatic Breast Cancer

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 705 (actual)
• Sponsor: iOMEDICO AG · Industry
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this non-interventional study is to collect data on the efficacy and safety of Nab-Paclitaxel in the routine application.

Detailed description

The main focus of this non-interventional study is set on answering the following questions: * Can the results observed in controlled clinical trials regarding efficacy and safety be reproduced in the routine clinical setting? * Are the side-effects of nab-paclitaxel therapy observed in this study comparable to the previously described safety-profile in terms of frequency and intensity? * What are the main reasons for modification or termination of the nab-paclitaxel therapy? * How does nab-paclitaxel therapy influence the patients' quality of life? * What are the criteria for selecting nab-paclitaxel as therapy for metastatic breast cancer?

Conditions

• Metastatic Breast Cancer

Timeline

• Start date: 2012-04-01
• Primary completion: 2015-11-01
• Completion: 2016-03-01
• First posted: 2012-09-21
• Last updated: 2018-06-20

Locations

1 site across 1 country: Germany